Brodsky & Smith Investigating LCI Industries, Iridium, Bio-Techne, and Arcosa Mergers

Regulation
โดย GlobeNewswire·Read original
Summary · why it matters

Brodsky & Smith is investigating the boards of LCI Industries, Iridium Communications, Bio-Techne Corporation, and Arcosa over potential fiduciary duty breaches in their respective merger agreements. LCI is being acquired by Patrick Industries in an all-stock deal where LCI shareholders would receive 1.2440 Patrick shares per LCI share. Iridium is being acquired by Rocket Lab for $54 per share in cash and stock, with an enterprise value of approximately $8.0 billion. Bio-Techne is being acquired by Merck KGaA for $73.00 per share in cash, representing a total enterprise value of approximately $11.3 billion. Arcosa is being acquired by CRH for $150.00 per share in cash, with a total enterprise value of approximately $8.5 billion. The investigations focus on whether the boards failed to conduct a fair process and whether shareholders are receiving fair value.

Impact on stocks 7

Space Economy▲ · 2 stocks
Iridium Communications Inc
IRDM
± MixedCapitalrelevance

Iridium is being acquired by Rocket Lab; investigation into board's process creates uncertainty but deal is ongoing.

Energy Transition & Power Demand▲ · 1 stocks
Arcosa Inc
ACA
± MixedCapitalrelevance

Arcosa is being acquired by CRH; investigation into board's process creates uncertainty but deal is ongoing.

Consumer Discretionary▲ · 1 stocks
LCI Industries
LCII
± MixedCapitalrelevance

LCI is being acquired by Patrick Industries; investigation into board's process creates uncertainty but deal is ongoing.

Biotech & Genomic Medicine▲ · 1 stocks
Bio-Techne Corp
TECH
± MixedCapitalrelevance

Bio-Techne is being acquired by Merck KGaA; investigation into board's process creates uncertainty but deal is ongoing.

Materials▲ · 1 stocks
Industrials▲ · 1 stocks
© 2026 MarketDXNews